4-{(4-Chlorophenyl)[4-(4-methylphenyl)-1,2,3-selenadiazol-5yl]methyl}-4,5, 6,7-tetra-hydro-1,2,3-benzoselenadiazole

  • J. Muthukumaran
  • , M. Nishandhini
  • , S. Chitra
  • , S. Muthusubramanian
  • , P. Manisankar
  • , Suman Bhattacharya
  • , R. Krishna
  • , J. Jeyakanthan

Research output: Contribution to journalArticlepeer-review

Abstract

In the title compound, C22H19ClN4Se 2, the mean plane of the non-fused selenadiazole ring forms dihedral angles of 54.20 (16)° and 70.48 (11)°, respectively, with the essentially planar [maximum deviations of 0.025 (5) and 0.009 (2) Å, respectively] methylphenyl and chlorophenyl substituents. The tetra-hydro-1,2,3-benzoselenadiazole group is disordered over two sets of sites with a refined occupancy ratio of 0.802 (5):0.198 (5). In the crystal, weak intermolecular C-H⋯N inter-actions are observed.

Original languageEnglish
Pages (from-to)o1421-o1422
JournalActa Crystallographica Section E: Structure Reports Online
Volume67
Issue number6
DOIs
Publication statusPublished - Jun 2011
Externally publishedYes

Fingerprint

Dive into the research topics of '4-{(4-Chlorophenyl)[4-(4-methylphenyl)-1,2,3-selenadiazol-5yl]methyl}-4,5, 6,7-tetra-hydro-1,2,3-benzoselenadiazole'. Together they form a unique fingerprint.

Cite this